The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
<p>Abstract</p> <p>Background</p> <p>the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from controlled studies on the efficacy of different init...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2474/12/94 |